This discovery ultimately gave rise to synthetic GLP-1 agonists, transforming the treatment of type 2 diabetes and, more recently, obesity.Though promising, it took decades before the discovery found its way into an FDA-approved drug
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
During high blood glucose levels, proinsulin biosynthesis and islet amyloid polypeptides (IAAP) are significantly increased in cells
(shown to double Natural Killer cell activity)
Macht einen wirklich professionellen Eindruck
Moreover, the effect of semaglutide on the pancreas is glucose-dependent and does not significantly increase the risk of hypoglycemia [3]